Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention

The regulatory and functional roles of non-coding RNAs are increasingly demonstrated as critical in cancer. Among non-coding RNAs, microRNAs (miRNAs) are the most well-studied with direct regulation of biological signals through post-transcriptional repression of mRNAs. Like the transcriptome, which...

Full description

Bibliographic Details
Main Authors: Raj Pranap Arun, Hannah F. Cahill, Paola Marcato
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/10/3/651
_version_ 1797472654975827968
author Raj Pranap Arun
Hannah F. Cahill
Paola Marcato
author_facet Raj Pranap Arun
Hannah F. Cahill
Paola Marcato
author_sort Raj Pranap Arun
collection DOAJ
description The regulatory and functional roles of non-coding RNAs are increasingly demonstrated as critical in cancer. Among non-coding RNAs, microRNAs (miRNAs) are the most well-studied with direct regulation of biological signals through post-transcriptional repression of mRNAs. Like the transcriptome, which varies between tissue type and disease condition, the miRNA landscape is also similarly altered and shows disease-specific changes. The importance of individual tumor-promoting or suppressing miRNAs is well documented in breast cancer; however, the implications of miRNA networks is less defined. Some evidence suggests that breast cancer subtype-specific cellular effects are influenced by distinct miRNAs and a comprehensive network of subtype-specific miRNAs and mRNAs would allow us to better understand breast cancer signaling. In this review, we discuss the altered miRNA landscape in the context of breast cancer and propose that breast cancer subtypes have distinct miRNA dysregulation. Further, given that miRNAs can be used as diagnostic and/or prognostic biomarkers, their impact as novel targets for subtype-specific therapy is also possible and suggest important implications for subtype-specific miRNAs.
first_indexed 2024-03-09T20:05:25Z
format Article
id doaj.art-05438e5e17b84a849a2d4172e6cb2dce
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T20:05:25Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-05438e5e17b84a849a2d4172e6cb2dce2023-11-24T00:33:20ZengMDPI AGBiomedicines2227-90592022-03-0110365110.3390/biomedicines10030651Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for InterventionRaj Pranap Arun0Hannah F. Cahill1Paola Marcato2Department of Pathology, Dalhousie University, Halifax, NS B3H 4R2, CanadaDepartment of Pathology, Dalhousie University, Halifax, NS B3H 4R2, CanadaDepartment of Pathology, Dalhousie University, Halifax, NS B3H 4R2, CanadaThe regulatory and functional roles of non-coding RNAs are increasingly demonstrated as critical in cancer. Among non-coding RNAs, microRNAs (miRNAs) are the most well-studied with direct regulation of biological signals through post-transcriptional repression of mRNAs. Like the transcriptome, which varies between tissue type and disease condition, the miRNA landscape is also similarly altered and shows disease-specific changes. The importance of individual tumor-promoting or suppressing miRNAs is well documented in breast cancer; however, the implications of miRNA networks is less defined. Some evidence suggests that breast cancer subtype-specific cellular effects are influenced by distinct miRNAs and a comprehensive network of subtype-specific miRNAs and mRNAs would allow us to better understand breast cancer signaling. In this review, we discuss the altered miRNA landscape in the context of breast cancer and propose that breast cancer subtypes have distinct miRNA dysregulation. Further, given that miRNAs can be used as diagnostic and/or prognostic biomarkers, their impact as novel targets for subtype-specific therapy is also possible and suggest important implications for subtype-specific miRNAs.https://www.mdpi.com/2227-9059/10/3/651microRNA (miRNA)breast cancersubtype specificitytriple negative breast cancer (TNBC)human epidermal growth factor receptor 2 (HER2)estrogen receptor (ER)
spellingShingle Raj Pranap Arun
Hannah F. Cahill
Paola Marcato
Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention
Biomedicines
microRNA (miRNA)
breast cancer
subtype specificity
triple negative breast cancer (TNBC)
human epidermal growth factor receptor 2 (HER2)
estrogen receptor (ER)
title Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention
title_full Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention
title_fullStr Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention
title_full_unstemmed Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention
title_short Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention
title_sort breast cancer subtype specific mirnas networks impacts and the potential for intervention
topic microRNA (miRNA)
breast cancer
subtype specificity
triple negative breast cancer (TNBC)
human epidermal growth factor receptor 2 (HER2)
estrogen receptor (ER)
url https://www.mdpi.com/2227-9059/10/3/651
work_keys_str_mv AT rajpranaparun breastcancersubtypespecificmirnasnetworksimpactsandthepotentialforintervention
AT hannahfcahill breastcancersubtypespecificmirnasnetworksimpactsandthepotentialforintervention
AT paolamarcato breastcancersubtypespecificmirnasnetworksimpactsandthepotentialforintervention